RecallRadar

FDA Device recall Z-1679-2022

Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use

On 2022-09-14 the FDA classified a Class II recall of Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use by Abbott Molecular, citing reports received of an increase of message code 9186 (internal control failed) when using the kit.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1679-2022
ClassificationClass II
Statusongoing
Initiated2022-08-19
Published2022-09-14
Last updated2026-09-13 11:56 UTC
CompanyAbbott Molecular
DistributionAZ, CA, CT, FL, GA, IL, KS, KY, LA, MA, MI, MN, MO, NC, NJ, NV, NY, OK, PA, RI, TN, TX, WA, WI

Product

Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use.

Reason

Reports received of an increase of message code 9186 (internal control failed) when using the kit.

Identifiers

code_infoLot #530738, UDI (01)00884999049208(10)530738(17)230527(240)09N78-085.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1679-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.